|
Tolerability of veliparib (V) in combination with carboplatin (C)/paclitaxel (P): Based chemoradiotherapy (CRT) in subjects with stage III non-small cell lung cancer (NSCLC). |
|
|
Consulting or Advisory Role - Vertex |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb (I) |
Research Funding - AbbVie; Bristol-Myers Squibb (I); Celldex (I); Immunocore (I); Merck (I); Reata Pharmaceuticals (I) |
|
|
Consulting or Advisory Role - Abbvie; ARIAD; Boehringer Ingelheim |
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech/Roche (Inst) |
|
|
Stock and Other Ownership Interests - Cardan Robotics; Mobius Imaging |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Epic Sciences |
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Genoptix; Heat Biologics; Novartis; Pfizer; Trovagene |
Speakers' Bureau - AstraZeneca; Genentech; Novartis; Pfizer |
Research Funding - BeyondSpring Pharmaceuticals |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Biodesix; EMD Serono; Genentech; Lilly; OncoPlex Diagnostics |
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Celgene (Inst); Merck (Inst); novartis (Inst); Pfizer (Inst) |
|
|
Patents, Royalties, Other Intellectual Property - Patent for brachytherapy device |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Abbvie |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
|
|
|
Stock and Other Ownership Interests - Abbvie |
|
|
Stock and Other Ownership Interests - McKesson |
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; Leidos Biomedical Research; Lilly; Merck; Merck Serono; Regeneron; Takeda; VentiRx |